Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 251.38M | $ 342.99M | $ 178.65M | $ 112.17M | $ 83.39M |
Total Assets | $ 7.97B | $ 10.14B | $ 9.97B | $ 9.00B | $ 9.23B |
Total Debt | $ 1.63B | $ 3.25B | $ 2.90B | $ 2.01B | $ 1.99B |
Net Debt | $ 1.38B | $ 2.91B | $ 2.72B | $ 1.90B | $ 1.91B |
Total Liabilities | $ 4.45B | $ 6.17B | $ 5.53B | $ 4.49B | $ 4.80B |
Stockholders Equity | $ 3.59B | $ 3.98B | $ 4.36B | $ 4.43B | $ 4.36B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |